Alzheimer's Patient Advocates Launch Free Courses Promoting Brain Health
May 26, 2022 14:37 ET
|
UsAgainstAlzheimer's
Washington, D.C., May 26, 2022 (GLOBE NEWSWIRE) -- Today UsAgainstAlzheimer’s announced the launch of The Brain Health Academy (BHA), a new series of free online courses designed in partnership with...
DAVOS ALZHEIMER’S COLLABORATIVE ANNOUNCES PARTNERSHIP WITH AGA KHAN UNIVERSITY TO LAUNCH FIRST ALZHEIMER’S RESEARCH INITIATIVE IN EAST AFRICA
May 23, 2022 09:53 ET
|
Davos Alzheimer's Collaborative
GENEVA, SWITZERLAND, May 23, 2022 (GLOBE NEWSWIRE) -- Research Will Produce Digital Cognitive Assessments and Collect Blood Samples for Gene Sequencing Models Clinical Trial Will Conduct...
DAVOS ALZHEIMER’S COLLABORATIVE ANNOUNCES EARLY DETECTION INNOVATION GRANTS
May 23, 2022 09:14 ET
|
Davos Alzheimer's Collaborative
GENEVA, SWITZERLAND, May 23, 2022 (GLOBE NEWSWIRE) -- The Davos Alzheimer’s Collaborative (DAC), the organization leading an unprecedented global response to Alzheimer’s disease, today announced the...
reMYND’s novel Alzheimer program reports excellent brain exposure and safety profile in Phase 1; transitioning into Phase 2a
May 03, 2022 02:00 ET
|
reMYND
PRESS RELEASE reMYND’s novel Alzheimer program reports excellent brain exposure and safety profile in Phase 1; transitioning into Phase 2a Leuven Belgium, 03 May 2022: reMYND NV, a clinical stage...
Alzheimer’s Patient Advocates File FOIA Seeking Answers on Discriminatory Medicare Coverage Decision
April 15, 2022 11:42 ET
|
UsAgainstAlzheimer's
Washington, D.C., April 15, 2022 (GLOBE NEWSWIRE) -- Today, UsAgainstAlzheimer’s announced their latest effort to demand answers from the Centers for Medicare and Medicare Services (CMS) about last...
Neurological Biomarkers Market by Application, by Type, by End-use, by Region and Forecasts to 2028
December 06, 2021 06:58 ET
|
Research and Markets
Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer's, Parkinson's), By Type (Genomic, Proteomic), By...
Actipulse Neuroscience Announces Successful Clinical Trial Using Fast Gamma Magnetic Stimulation for the Treatment of Alzheimer's Disease
September 30, 2021 15:00 ET
|
Actipulse Neuroscience
BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Today, the results of a recent pilot clinical trial, funded by neurotech company Actipulse Neuroscience, have demonstrated that its non-invasive...
Outlook on the Neurological Diseases Treatment Global Market to 2029 - Key Drivers, Challenges and Opportunities
April 29, 2021 07:18 ET
|
Research and Markets
Dublin, April 29, 2021 (GLOBE NEWSWIRE) -- The "Neurological Diseases Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
Longeveron Inc. to Present at the Q1 Virtual Investor Summit on March 24
March 19, 2021 07:45 ET
|
Longeveron Inc.
MIAMI, March 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for...
LSU Professor Gartia Receives NSF CAREER Award for Alzheimer’s Research
March 03, 2021 12:20 ET
|
LSU College of Engineering
BATON ROUGE, La., March 03, 2021 (GLOBE NEWSWIRE) -- LSU Mechanical Engineering Professor Manas Gartia was recently given a National Science Foundation CAREER Award for his project, “Multimodal...